Clinical Trials and Research
A
A
Change Text Size
Studies Currently Enrolling
Age-Related Macular Degeneration
Exudative ('Wet') Age-Related Macular Degeneration
Ladder Study
Phase II Study evaluating extended delivery of intravitreal Lucentis using a refillable implant. Sponsored by Genentech
Fovista Study
Phase III Study evaluating Avastin or Eylea in combination with Fovista (anti-Platelet Derived Growth Factor Drug) for the treatment of Choroidal neovascularization due to ARMD. Sponsored by Ophthotech
Emerge Study
Study evaluating intravitreal injection of hI-con1 as monotherapy or in combination with Lucentis as compared with Lucentis in patients with choroidal Neovascularization Secondary to ARMD. Sponsored by ICONIC
Sequoia Study
Study evaluating abicipar (an antiVEGF drug) as monotherapy compared with Lucentis for patients with choroidal neovascularization in AMD. Sponsored by Allergan
Non-Exudative ('Dry') Age-Related Macular Degeneration
Chroma Study
Phase III Study evaluating intravitreal lampalizumab (Anti-Complement Factor D Drug) for treatment of patients with Geographic Atrophy due to ARMD. Sponsored by Genentech.
Exposure Study
PHASE II Multi-center, randomized, sham injection-controlled exposure-response study of Lampalizumab intravitreal injections administered every two weeks or every four weeks to patients with geographic atrophy
Seattle
Emixustat for treatment of Geographic Atrophy. Sponsored by Acucela. NOTE THAT ENROLLMENT FOR THIS STUDY IS COMPLETED
Retinal Vein Occlusion
Ozurdex for RVO
Study evaluating Ozurdex implant for patients with macular edema due to RVO resistant to prior intravitreal injections of anti VEGF drugs. CLOSED TO FURTHER ENROLLMENT
Sponsored by Allergan.
Diabetic Macular Edema (DME)
Vista
Eylea for Diabetic Macular Edema. Sponsored by Regeneron. NOTE THAT ENROLLMENT FOR THIS IS COMPLETED.
Future Studies Involvement Scheduled. Enrollment dates Pending.
Genetic Study Investigations
Eyegene
Study evaluating genetics of retinal dystrophies and degenerations
Completed Studies
Collaborative Ocular Melanoma Study- Sponsored by National Eye Institute
Submacular Surgery Trial- Sponsored by National Eye Insititute
Complications of Age-Related Prevention Trial (CAPT)- Sponsored by National Eye Institute
Comparison of Age-Related Macular Degeneration Treatment Trial (CATT)- Sponsored by National Eye Institute
Diabetic Retinopathy Clinical Research Network (DCCR)
Intravitreal Triamcinolone vs. Grid Laser
Standard of Care vs Corticosteroid for Retinal Vein Occusion Study (SCORE)
High Dose Lucentis for the Treatment of Exudative Age-Related Macular Degeneration (Harbor Trial)- Sponsored by Genentech
Lucentis Treatment of Retinal Vein Occlusion (SHORE)- Sponsored by Genentech
Lucentis Treatment for Exudative Age-Related Macular Degeneration (Marina Trial)- Sponsored by Genentech
Age-Related Eye Disease Study II (AREDS II)
Lucentis for Branch Retinal Vein Occlusion (BRAVO)- Sponsored by Genentech
Lucentis for Central Retinal Vein Occlusion (CRUISE)- Sponsored by Genentech
Lucentis for Retinal Vein Occlusion (HORIZON)
Lucentis for AMD Patients Previously Enrolled in MARINA/FOCUS Trials (HORIZON)- Sponsored by Genentech
Lucentis for Age-Related Macular Degeneration (SAILOR)- Sponsored by Genentech
Lucentis vs. Visudyne Photodynamic Therapy (DENALI)
Phase i/II Study of Lucentis vs. Visudyne (FOCUS)
VIT-1000
Visudyne/Intravitreal Triamcinolone vs. Visudyne/Macugen for AMD (VERITAS)
Visydyne for Minimally Classic AMD (VMC)
ASPEN Study for Non-Insulin Dependant Diabetes
Transpupillary Thermotherapy for Choroidal Neovascularization (TTT4CNV)
Choroidal Neovascularization Prevention Trial Pilot Study (CNVPT)
Interferon for Age-Related Macular Degeneration
Radiation Treatment for ARMD
Microplasmin for Non-Surgical Treatment of Vitreomacular Traction Syndrome- Sponsored by Thrombogenics)
Lucentis for Diabetic Macular Edema (RISE)- Sponsored by Genentech